background
cytokin
associ
modul
inflamm
may
benefici
clear
influenza
infect
experiment
model
cytokin
profil
evalu
pilot
studi
respiratori
viru
infect
method
consecut
patient
symptom
respiratori
tract
infect
visit
emerg
depart
tertiari
care
hospit
winter
influenza
season
evalu
clart
pneumovir
kit
genomica
madrid
spain
use
viral
detect
known
respiratori
virus
cytokin
profil
evalu
milliplex
map
human
magnet
bead
panel
millipor
corp
billerica
correl
profil
viral
detect
perform
univari
multivari
analysi
result
seventysix
patient
evalu
median
age
year
femal
respiratori
viru
identifi
patient
confirm
influenza
signific
interplay
innat
adapt
immun
control
respons
respiratori
viral
infect
influenza
upon
infect
human
cell
recogn
pattern
recognit
receptor
lead
mobil
innat
immun
system
secret
chemokin
cytokin
sequenc
event
neighbor
innat
immun
cell
activ
transform
growth
latent
form
result
secret
chemokin
interleukin
parenchym
inflammatori
cell
initi
phase
immun
respons
crucial
role
contribut
proinflammatori
cytokin
member
inter
propos
associ
modul
inflamm
may
benefici
clearanc
influenza
infect
howev
other
suggest
potenti
role
increas
diseas
relat
sever
anim
model
limit
data
suggest
associ
exagger
system
respons
sever
diseas
respiratori
involv
patient
suffer
pandem
influenza
caus
strain
current
studi
evalu
cytokin
profil
pilot
studi
respiratori
viru
infect
molecular
test
use
viru
identif
seventysix
patient
evalu
median
age
year
interquartil
rang
iqr
year
femal
respiratori
viru
identifi
patient
tabl
laboratori
cytokin
data
per
specif
viru
infect
patient
studi
depict
tabl
data
addit
shown
six
healthi
volunt
significantli
lower
cytokin
valu
rest
group
p
comparison
tabl
elev
creactiv
protein
level
valu
note
patient
seen
tabl
normal
valu
less
mgl
highest
creactiv
protein
level
valu
seen
piv
detect
reach
statist
signific
compar
level
seen
virus
includ
type
influenza
identifi
signific
associ
cascad
specif
clinic
paramet
like
presenc
fever
height
fever
eg
wheez
myalgia
presenc
dri
product
cough
presenc
nasal
symptom
show
statist
signific
neg
correl
studi
cytokin
except
p
comparisonindepend
sampl
test
logist
regress
model
adjust
age
presenc
comorbid
interact
term
wbc
crp
level
level
found
age
ci
p
well
level
ci
unclear
involv
immun
respons
influenza
piv
infect
crucial
role
inflamm
found
microbi
clearanc
hand
uncontrol
signal
associ
autoimmun
diseas
even
cancer
progress
specif
famili
member
discret
role
human
immun
eg
mainli
involv
mucos
host
defens
mechan
wherea
amplifi
immun
respons
last
year
studi
examin
role
pathway
human
influenza
infect
none
knowledg
human
respiratori
infect
comparison
virus
affect
respiratori
tract
recent
literatur
suggest
adapt
immun
may
involv
clearanc
influenza
virus
respiratori
tract
immun
system
patient
suffer
influenza
respond
releas
sever
proinflammatori
cytokin
among
cascad
cytokin
appear
central
role
symptom
gener
local
inflammatori
effect
clinic
relev
cytokin
storm
recruit
neutrophil
monocyt
macrophag
site
infect
may
associ
sever
diseas
outcom
appear
depend
pathogen
viru
host
respons
role
process
clearli
delin
yet
although
import
increasingli
recogn
studi
shown
posit
associ
mild
increas
level
two
studi
patient
sever
affect
pandem
viru
higher
level
note
milder
case
find
consist
enhancedvir
clearanc
one
studi
mark
suppress
adapt
immun
influenza
compar
season
type
type
b
influenza
anoth
studi
pediatr
infect
novel
pandem
viru
higher
level
seen
patient
pandem
infect
compar
control
pneumonia
attribut
caus
moreov
higher
correl
diseas
sever
nevertheless
studi
differ
mildli
sever
affect
patient
increas
patient
suffer
diffus
alveolar
damag
seen
one
experiment
lung
immunopatholog
autopsi
studi
patient
affect
pandem
viru
regard
rsv
observ
limit
literatur
suggest
role
cytokin
rsv
pathogen
one
infant
studi
level
associ
reduct
clinic
symptom
respiratori
distress
lower
level
cytokin
patient
rsv
studi
might
contribut
inabl
properli
control
host
inflammatori
respons
lead
seriou
diseas
pattern
sicker
patient
rsv
hospit
longer
sampl
site
exampl
nasal
sampl
bal
sever
case
would
assist
better
understand
differ
synergi
local
compar
system
cytokin
effect
addit
although
care
record
analyz
data
variabl
potenti
advers
affect
effect
immun
respons
could
account
residu
confound
studi
hypothes
mechan
behind
differ
cytokin
profil
observ
influenza
b
effort
influenza
b
infect
remain
less
studi
influenza
human
anim
despit
fact
associ
signific
number
respiratori
infect
case
winter
contrari
find
studi
patient
compar
cytokin
level
type
vs
type
b
influenza
hallmark
cytokin
cell
subset
along
level
significantli
higher
type
b
influenza
less
virul
circul
b
strain
could
explain
find
anim
studi
use
immunosuppressedmous
model
influenza
b
infect
cytokin
panel
includ
evid
import
contribut
pathogen
moreov
differ
degre
immunopatholog
caus
two
differ
influenza
b
virus
victoria
lineag
viru
virul
associ
greater
morbid
lethal
experi
interestingli
period
studi
main
influenza
b
strain
across
europ
greec
belong
yamagata
lineag
due
small
sampl
studi
f
g
u
r
e
continu
antali
et
al
differ
verifi
studi
would
specif
examin
differ
lineag
viru
final
role
effect
influenza
system
assess
effort
exampl
mous
model
respiratori
influenza
signific
respons
intestin
associ
immun
intestin
injuri
develop
diarrhea
note
furthermor
neutral
reduc
intestin
injuri
intestin
microbiota
chang
relat
influenza
virusmedi
cytokin
chang
interest
field
human
research
could
assess
current
effort
conclus
describ
famili
cytokin
level
associ
respiratori
viral
infect
confirm
molecular
method
pilot
studi
largescal
studi
patient
respiratori
viral
infect
would
assist
concur
understand
observ
upregul
main
cell
effector
cytokin
relat
specif
type
respiratori
virus
associ
especi
one
observ
influenza
piv
novel
merit
consider
even
find
come
small
pilot
futur
verif
studi
result
well
exploit
cytokin
pathway
diagnost
therapeut
prognost
purpos
may
greatli
assist
manag
common
potenti
seriou
viral
respiratori
infect
necessari
http
